Showing 1 - 9 results of 9 for search 'Mercedes Porosnicu', query time: 0.03s Refine Results
  1. 1
    A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers

    A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers by Kimberly M. Burcher, Jack T. Burcher, Logan Inscore, Chance H. Bloomer, Cristina M. Furdui, Mercedes Porosnicu

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status

    Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status by Mercedes Porosnicu, Mercedes Porosnicu, Anderson O’Brien Cox, Joshua D. Waltonen, Paul M. Bunch, Ralph D’Agostino, Ralph D’Agostino, Thomas W. Lycan, Thomas W. Lycan, Richard Taylor, Dan W. Williams, Xiaofei Chen, Kirtikar Shukla, Brian E. Kouri, Tiffany Walker, Tiffany Walker, Gregory Kucera, Gregory Kucera, Hafiz S. Patwa, Hafiz S. Patwa, Christopher A. Sullivan, Christopher A. Sullivan, J. Dale Browne, J. Dale Browne, Cristina M. Furdui, Cristina M. Furdui

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

    Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case repor... by Chance H. Bloomer, Elena Gavrila, Kimberly M. Burcher, John M. Kalada, Mark J. Chang, Rediet R. Gebeyehu, Elsabeth Asare, Lara M. Khoury, Rebecca Kinney, Bart Frizzell, Christopher A. Sullivan, Paul M. Bunch, Mercedes Porosnicu

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature

    Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature by Lara M. Khoury, Kimberly M. Burcher, Ronald T. Ng, Alexander H. Song, Mark J. Chang, Elena Gavrila, Chance H. Bloomer, Mac B. Robinson, Brian E. Kouri, Joshua D. Waltonen, Paul M. Bunch, Ulrich M. Lauer, Mercedes Porosnicu

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC

    Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC by Kimberly M. Burcher, Andrew T. Faucheux, Jeffrey W. Lantz, Harper L. Wilson, Arianne Abreu, Kiarash Salafian, Manisha J. Patel, Alexander H. Song, Robin M. Petro, Thomas Lycan, Cristina M. Furdui, Umit Topaloglu, Ralph B. D’Agostino, Wei Zhang, Mercedes Porosnicu

    Published 2021-06-01
    Get full text
    Article
  6. 6
    Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma

    Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma by Kimberly M. Burcher, Jeffrey W. Lantz, Elena Gavrila, Arianne Abreu, Jack T. Burcher, Andrew T. Faucheux, Amy Xie, Clayton Jackson, Alexander H. Song, Ryan T. Hughes, Thomas Lycan, Paul M. Bunch, Cristina M. Furdui, Umit Topaloglu, Ralph B. D’Agostino, Wei Zhang, Mercedes Porosnicu

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer

    Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer by Kimberly M. Burcher, Chance H. Bloomer, Elena Gavrila, John M. Kalada, Mark J. Chang, Rediet R. Gebeyehu, Alexander H. Song, Lara M. Khoury, Thomas W. Lycan, Rebecca Kinney, Ralph D’Agostino, Paul M. Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M. Furdui, Wei Zhang, Mercedes Porosnicu

    Published 2024-01-01
    Get full text
    Article
  8. 8
    Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO

    Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO by Zhiwei Ji, Jade Moore, Nelmi O. Devarie-Baez, Joshua Lewis, Joshua Lewis, Hanzhi Wu, Kirtikar Shukla, Elsa I. Silva Lopez, Victor Vitvitsky, Chia-Chi Chuang Key, Mercedes Porosnicu, Melissa L. Kemp, Melissa L. Kemp, Ruma Banerjee, John S. Parks, Allen W. Tsang, Xiaobo Zhou, Cristina M. Furdui

    Published 2023-01-01
    Get full text
    Article
  9. 9
    Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages

    Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages by Meng Yang, Umit Topaloglu, W. Jeffrey Petty, Matthew Pagni, Kristie L. Foley, Stefan C. Grant, Mac Robinson, Rhonda L. Bitting, Alexandra Thomas, Angela T. Alistar, Rodwige J. Desnoyers, Michael Goodman, Carol Albright, Mercedes Porosnicu, Mihaela Vatca, Shadi A. Qasem, Barry DeYoung, Ville Kytola, Matti Nykter, Kexin Chen, Edward A. Levine, Edgar D. Staren, Ralph B. D’Agostino, Robin M. Petro, William Blackstock, Bayard L. Powell, Edward Abraham, Boris Pasche, Wei Zhang

    Published 2017-05-01
    Get full text
    Article

Search Tools: